An interventional study of Culturally-adapted cognitive-behavioural therapy in Psychosis and Schizophrenia Spectrum Disorders, sponsored by University of Manchester. Recruiting at 1 site in United Kingdom. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2026-07-10.
Sponsored by University of Manchester · Not applicable, Interventional, and Treatment
The goal of this case series study is to learn if culturally-adapted cognitive-behavioural therapy is practical, acceptable and safe among Black Sub-Saharan African and Caribbean people experiencing psychosis. The main question it aims to answer is:
Is culturally-adapted CBT for psychosis feasible, acceptable to and safe for Black Sub-Saharan African and Caribbean people experiencing psychosis?
Participants will be asked to:
1,587 studies on the registry are indexed under Psychotic Disorders; 281 are open to participants now.
This study's planned enrollment of 6 is below the median of 65 across 1,320 interventional studies indexed under Psychotic Disorders.
Browse Psychotic Disorders studies →University of Manchester is the lead sponsor of 201 studies on the registry; 44 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Behavioral: Culturally-adapted cognitive-behavioural therapy
Cognitive-behavioural therapy for psychosis culturally-adapted for Black Sub-Saharan African and Caribbean people using a dedicated, integrated treatment manual
Semi-structured qualitative interview: Service user acceptability
Service user satisfaction as assessed by qualitative interview.
Time frame: End of therapy (16 weeks)
Working Alliance Inventory-Short Form Revised
Acceptability measured sessionally using the Working Alliance Inventory-Short Form Revised (Hatcher \& Gillaspy, 2006)
Time frame: End of therapy (16 weeks)
Adverse Events Checklist
Safety monitored sessionally using an Adverse Events Checklist developed for this study
Time frame: Each therapy session (16 weeks)
Subjective Experience of Psychosis Scale
Subjective distress measured by the Subjective Experience of Psychosis Scale (Haddock et al., 2011)
Time frame: End of therapy (16 weeks)
Questionnaire about the Process of Recovery
Perceived recovery measured by the Questionnaire about the Process of Recovery (Law et al., 2014)
Time frame: End of therapy (16 weeks)
Depression, Anxiety and Stress Scales
Emotional wellbeing measured by the Depression, Anxiety and Stress Scales (Lovibond \& Lovibond, 1995)
Time frame: End of therapy (16 weeks)
Plan to share: No
No publications or documents are linked to this record.
Started Feb 2026 (actual). Primary completion is estimated for Dec 2026, 10 months after the start.
Of 455 non-industry interventional studies with no phase under Psychotic Disorders, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 52. This study's planned 10 months is below that.
Counting every sponsor, half of 457 studies reached it within 34 months; a quarter within 19 and three quarters within 52.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.